Click on the image above (or here) to read the latest edition in the Clinical Trials eBook Series.
With new technologies constantly being developed and implemented, as well as new operational approaches enforced by COVID-19 lockdowns, the future of clinical trials is more uncertain, and more exciting, than it has been in a long time.
The pandemic put huge pressure on clinical studies across the globe, forcing researchers to completely change their way of working. From novel approaches to patient recruitment, and remote monitoring and paperless trials, to the use of use of Real World Evidence, and fully decentralized or virtual trials, the implementation of broad ranging innovations has been accelerated.
Indeed, our research has shown that 70% of the industry have been involved in or worked on trials that have implemented some decentralized element in the last two years. There has clearly been a huge impact on trials in the short term, but which of these changes are going to remain long term?
The speed and success of the vaccine trials has also shown there is a different way of running trials, which in an unexpected way has put pressure on all other trials to improve. In this eBook, pci explore one aspect of this, looking at the importance and process of delivering the full value chain for oncology clinical trials.
In this eBook in partnership with pci we explore how all these areas are combining to impact the future of clinical trials, looking at the trends we can expect to see in the coming years and how to stay ahead of the curve.
Click on the image above (or here) to read the latest edition in the Clinical Trials eBook Series.